Changes in revenues associated with antimicrobial reimbursement reforms in Germany

10 August 2024 - Policy declarations from the G7 and other high-level meetings call for increased incentives for antimicrobial research and ...

Read more →

The lifecycle of a rare disease cancer drug

10 October 2017 - One pharma company’s medicine illustrates how firms can benefit from different layers of market-exclusivity protections. ...

Read more →